Cürari is positioning itself for a larger role in the rapidly evolving U.S. healthcare market.
During a private company event held Friday in Miami, the health-tech platform introduced the next stage of its expansion and announced Colombian entrepreneur and technology executive Diego Urquijo as its new Executive Partner.
The appointment reflects Cürari's ambition to become more than a provider of virtual consultations or physician-prescribed wellness treatments. The company is building a broader healthcare experience designed around the medical needs, cultural expectations and digital habits of Hispanic patients in the United States.
A cross-border foundation
One of the leaders behind that vision is Linda Paola Ortiz, known online as @dra.smile305, a Colombian cosmetic dentist who has built a prominent career treating Hispanic artists, entertainers and public figures.
Paola is also the clinical force behind Smile Dental Center Group, with operations in Miami and Medellín, Colombia. Over more than 15 years, she has developed a cross-border practice that combines cosmetic dentistry, advanced technology and highly personalized patient care.
Her work has earned her recognition within the Hispanic entertainment community, where she has become known for designing smiles for celebrities and other high-profile clients from across Latin America and the United States.
Cürari represents an expansion of that vision.
Rather than focusing exclusively on cosmetic dentistry, Paola is helping build a healthcare company capable of serving a much broader population. The platform aims to make medical access feel more personal, convenient and culturally relevant for Hispanic patients.
“Cürari was created from the belief that Hispanic patients deserve more than translated healthcare.”
“Cürari was created from the belief that Hispanic patients deserve more than translated healthcare,” Paola said. “They deserve an experience designed around their language, their culture, their concerns and the way they want to be treated.”
Cürari provides access to a nationwide healthcare network that includes more than 15,000 physicians across the United States. Through its digital platform, patients can connect with licensed medical professionals, complete clinical evaluations and access physician-prescribed treatments through a streamlined, technology-enabled experience.
Closing the access gap
The company is built around a straightforward idea: healthcare may be widely available in the United States, but accessing it can still be confusing, impersonal and difficult to navigate.
Those challenges can be even greater for Hispanic patients seeking clear communication, cultural familiarity and a stronger sense of trust throughout the medical process.
Cürari believes technology can help close that gap.
The company is developing an integrated platform that brings together licensed medical care, digital patient support, physician-prescribed treatments and a more accessible consumer experience.
Its goal is not simply to move traditional healthcare services online. It is to rethink how patients discover, understand and receive care.
Metabolic health and physician-supervised peptides
A central part of Cürari's vision is its focus on metabolic health, preventive care and physician-supervised peptide therapies.
Peptides have become one of the most closely watched areas in personalized medicine, with potential applications across metabolic health, recovery, healthy aging and overall wellness. Cürari believes these therapies may play an important role in the future of healthcare when they are prescribed responsibly, selected according to each patient's individual needs and monitored by licensed medical professionals.
The company is not positioning peptides as shortcuts, universal solutions or replacements for proper medical care. Instead, it is building a clinical model in which patients receive medical evaluations, individualized treatment plans and ongoing professional oversight.
For Cürari, the larger opportunity lies in making emerging treatments more understandable and accessible without removing medicine from the process.
That philosophy reflects one of the company's core convictions: innovation should not replace physicians. It should give physicians better tools and give patients a more informed, personalized healthcare experience.
Interest in peptide therapies has grown alongside broader changes in consumer health behavior. Patients are increasingly looking beyond reactive care and seeking earlier intervention, more personalized treatment options and ongoing access to licensed professionals who can help them understand both the potential and limitations of emerging therapies.
That places Cürari within a broader transformation taking place across the economy.
Financial services were reshaped by fintech. Education was disrupted by edtech. Healthcare is now undergoing a similar shift as patients increasingly expect faster access, clearer communication and more personalized service.
Diego's appointment signals that Cürari intends to participate in that shift not only as a healthcare company, but also as a technology business.
Diego leads Urpe AI Lab and has built and invested in companies across artificial intelligence, legal technology, education and digital infrastructure. Much of his work has focused on using artificial intelligence and autonomous systems to improve how companies attract customers, manage operations and scale.
As Executive Partner, Diego will help guide Cürari's growth strategy, technology development, market positioning and national expansion.
“Healthcare should not become less human as it becomes more technological.”
“Healthcare should not become less human as it becomes more technological,” Diego said. “The real opportunity is to use technology to make medical access simpler, more personal and more trustworthy.”
Two complementary leaders
The partnership brings together two leaders with distinctly different but complementary backgrounds.
Paola brings years of direct experience serving Hispanic patients, building trusted healthcare brands and operating clinics in both the United States and Colombia.
Diego brings experience in technology, artificial intelligence, commercial strategy and the development of scalable companies.
Together with Cürari's broader leadership team, they are working to create a platform that combines clinical credibility with the simplicity and convenience consumers increasingly expect from modern technology companies.
For Cürari, the Hispanic market is not simply another customer segment. It is the community around which the company is designing its brand, communication and patient experience.
That distinction is central to its strategy.
Many healthcare companies build services for the general market and later translate portions of the experience into Spanish. Cürari is taking a different approach by developing its platform with Hispanic patients in mind from the beginning.
That includes communication that feels familiar, access to licensed physicians, a simpler digital journey and a brand capable of discussing health without making the experience feel distant or overly clinical.
Paola's background provides an important foundation for that approach.
Her career has been built not only on clinical expertise, but also on understanding how Hispanic patients make healthcare decisions, what earns their trust and how a medical brand can remain aspirational without losing its personal connection to the people it serves.
A market at an inflection point
Cürari is entering the market at a time when metabolic health, longevity, preventive care and medically supervised wellness treatments are reshaping how consumers think about their health.
Patients are no longer looking only for treatment after something goes wrong. Many are seeking greater control over their health, earlier access to professional guidance and treatment plans designed around their individual goals.
That creates a significant opportunity for companies capable of combining medicine, technology and trust.
It also creates significant responsibility.
Healthcare companies operate in an environment where physician oversight, patient safety, clinical credibility and regulatory compliance matter just as much as branding and convenience.
The companies most likely to succeed over the long term will be those capable of delivering a modern consumer experience without compromising medical standards.
Cürari believes its physician network, founding leadership and technology platform can provide that foundation.
A declaration of intent
Friday's event marked a shift in how the company intends to present itself publicly.
Cürari is no longer defining its mission solely through individual products or treatments. It is beginning to articulate a much larger ambition: to become a leading health-tech platform for Hispanic America.
Diego's appointment is part of that transition.
His arrival connects Cürari with a broader ecosystem of artificial intelligence, technology and company-building experience. It also gives the company a more visible executive voice as it prepares for its next stage of growth.
“We want to help shape what that future looks like for millions of Hispanics in the United States.”
“Our goal is not simply to participate in the future of healthcare,” Diego said. “We want to help shape what that future looks like for millions of Hispanics in the United States.”
For Paola, Cürari also represents the natural evolution of a career centered on transforming how patients feel about their health, confidence and personal well-being.
What began with the transformation of individual smiles is now expanding into a broader mission: building a healthcare experience capable of serving an entire community.
Friday's event was both a celebration and a declaration of intent.
Cürari is betting that the next major healthcare platform for Hispanic America will not be built by simply translating an existing model.
It will be built by understanding the community first—and designing its technology, clinical services and patient experience around it.